Back to search
FDAFDA · Food and drugs·Recall number D-0337-2019

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3.

Published December 26, 2018 · Recall initiated: November 26, 2018

Summary

FDA records drug Class II recall D-0337-2019, published December 26, 2018 and initiated November 26, 2018. Recalling firm: Tris Pharma Inc.; Status: Terminated; Reported quantity: 20,736 bottles; Lot: Lot #: 00717024A, Exp 08/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tris Pharma Inc.
Distributor
One distributor in PA who further distributed Nationwide in the USA.
Lot
Lot #: 00717024A, Exp 08/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3. recalled?

Yes. FDA published recall D-0337-2019 on December 26, 2018. Reported hazard: Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

What should I do if I have this product?

Voluntary: Firm initiated · Letter